More than half of patients with fingernail psoriasis achieved complete fingernail clearance after 68 weeks of guselkumab treatment.

Two posters presented at the 2025 American Academy of Dermatology Annual Meeting highlighted the importance of improving ...

Acitretin, isotretinoin, and ultraviolet B are less frequently used than other class I treatments for lichen planus, such as topical corticosteroids.

American Academy of Dermatology President Seemal R. Desai, MD, FAAD ...

Ruxolitinib cream 1.5% shows “breakthrough” results as a treatment for prurigo nodularis, according to a presenter at the ...

American Academy of Dermatology (AAD) meeting, Steven Daveluy, M.D., associate professor and program director of dermatology ...

Eli Lilly And Co (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) said adolescent patients with severe alopecia areata (AA) ...

Steven Daniel Daveluy, MD, FAAD, advocates for dermatologists to adopt cultural humility, engage in continuous education, and navigate ethical considerations to provide equitable and supportive care ...

Positive results from ADEPT phase 2/3 study of Dupixent in adults with moderate-to-severe bullous pemphigoid presented at AAD: Paris Tuesday, March 11, 2025, 14:00 Hrs [IST] Posit ...

Incyte Corporation (NASDAQ:INCY) revealed results from its pivotal Phase 3 TRuE-PN clinical trial program –TRuE-PN1 and ...

Results from the phase 3 ICONIC-LEAD study presented at this year’s American Academy of Dermatology (AAD) annual meeting ...

Wingderm® once again participated in the 2025 AAD Annual Meeting, which was held in Orlando, Florida, from March 7 to 9. The American Academy of Dermatology is the largest, most influential, and most ...